Dhingra Kapil (CIK 1456849) reported 3 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-12-11). Recent activity: Buy REPL (3,169 shares), Sell REPL (3,169 shares), Sell LVTX (30,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-11 | Replimune Group, Inc. (REPL) | Director | Buy | 3,169 | $5,546 |
| 2025-12-11 | Replimune Group, Inc. (REPL) | Director | Sell | 3,169 | $32,958 |
| 2025-11-17 | LAVA Therapeutics NV (LVTX) | Director | Sell | 30,000 | $0 |
Source: SEC Form 4 filings · as of 2025-12-11